Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT00663403
Eligibility Criteria:
Inclusion Criteria:
* =/\> 18 years of age
* Prescribed Continuous Venovenous Hemodialysis (CVVHD) as determined by the primary physician
* Prescribed daptomycin as determined by the primary physician
* Informed consent granted
Exclusion Criteria:
* \< 18 years of age
* Allergy to daptomycin
* Patients being primarily treated with daptomycin for diagnosis of osteomyelitis, meningitis, or pneumonia without adequate concomitant use of other more effective antimicrobial agents as daptomycin is not indicated for primary treatment of these types of infections
* Inability to complete 48 hours of Continuous Venovenous Hemodialysis (CVVHD)
* Concurrent use of other extracorporeal therapies such as Extracorporeal Membrane Oxygenation (ECMO) or plasmapheresis and intermittent hemodialysis
* Inability to obtain informed consent
* Pregnant and/or breastfeeding women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00663403
Study Brief:
Protocol Section:
NCT00663403